REGN

Regeneron Pharmaceuticals, Inc. News Headlines

$322.18
*  
17.67
5.8%
Get REGN Alerts
*Delayed - data as of Jul. 30, 2014  -  Find a broker to begin trading REGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    REGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Regeneron's Eylea Gets FDA Nod for Diabetic Macular Edema - Analyst Blog
7/30/2014 7:00:00 PM - Zacks.com

BioMarin Sells Priority Review Voucher To Regeneron
7/30/2014 5:42:00 PM - Dow Jones Business News

S&P 500 Movers: GNW, EW
7/30/2014 11:28:22 AM - BNK Invest

Nasdaq 100 Movers: GRMN, REGN
7/30/2014 11:27:43 AM - BNK Invest

Regeneron Pharmaceuticals Inc. (REGN) Is Surging On Phase 3 Study Results
7/30/2014 9:32:00 AM - RTT News

Sanofi And Regeneron: 9 Phase 3 ODYSSEY Trials Of Alirocumab Met Primary Goal
7/30/2014 8:19:00 AM - RTT News

Sanofi, Regeneron's Alirocumab Shows Promise in Phase III Trials
7/30/2014 8:14:00 AM - Dow Jones Business News

ADMP Awaits Decision, REGN Can Catch Your Eye, SQNM Does A Deal, ZLTQ Goes Cool
7/30/2014 6:25:00 AM - RTT News

FDA Approves Bayer's Eylea for Diabetic Macular Edema Treatment
7/30/2014 3:50:00 AM - Dow Jones Business News

Cramer's Mad Money: The 4 Horsemen Trample Big Pharma (7/23/14)
7/24/2014 6:01:00 AM - Seeking Alpha

Bayer/Regeneron Continue to Progress with Eylea - Analyst Blog
7/22/2014 5:20:00 PM - Zacks.com

Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?
7/21/2014 10:40:00 AM - Seeking Alpha

InsiderInsights.com Daily Round Up: 7/17/14
7/18/2014 10:28:00 AM - Seeking Alpha

Sector Update: Health Care Shares Mixed Pre-Market
7/18/2014 8:45:52 AM - MT Newswires

Sector Update: Health Care
7/18/2014 8:45:26 AM - MT Newswires

Regeneron Reports Results From Phase3 Trial Of EYLEA Injection For DME Treatment
7/18/2014 6:20:00 AM - RTT News

Notable Two Hundred Day Moving Average Cross - REGN
7/17/2014 4:58:34 PM - BNK Invest

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Analyst Blog
7/16/2014 9:49:00 AM - Zacks.com

Some Elegant Biotech Platforms I Read About While Looking For The Next Regeneron
7/16/2014 9:42:00 AM - Seeking Alpha

InsiderInsights.com Daily Round Up: 7/15/14
7/16/2014 9:21:00 AM - Seeking Alpha

InsiderInsights.com Daily Round Up: 7/14/14
7/15/2014 12:22:00 PM - Seeking Alpha

InsiderInsights.com Daily Round Up: 7/10/14
7/11/2014 7:42:00 AM - Seeking Alpha

Sanofi/Regeneron Announce Encouraging Dupilumab Data - Analyst Blog
7/10/2014 4:30:00 PM - Zacks.com

Cramer's Mad Money - The 4 Horsemen Of Biotech Ride On (7/9/14)
7/10/2014 6:27:00 AM - Seeking Alpha

The Rise And Rise Of Regeneron...
7/10/2014 4:22:00 AM - RTT News